High myopia linked to higher education levels

Article

Attaining a higher level of education and spending more years in school have been linked to a greater prevalence and severity of myopia, according to a study recently published in Ophthalmology.

San Francisco-Attaining a higher level of education and spending more years in school have been linked to a greater prevalence and severity of myopia, according to a study recently published in Ophthalmology.

According to researchers, 4,658 participants between the ages of 35 and 74 were given a comprehensive questionnaire; a thorough ophthalmic, cardiovascular, psychological, and general examination; and laboratory tests, in order to determine the prevalence and magnitude of myopia in association with the number of years spent in school and level of post-school professional education.

Playing outdoors helps reduce risk of myopia in kids

The results of the study found that 24 percent of participants with no high school education or other training were myopic; 35 percent of high school graduates and vocational school graduates were myopic; and 53 percent of university graduates were myopic. The study also found that the participants who spent more years in school were more myopic, with the myopia worsening for each year of school.

Researchers also looked at the effect of genetics on the degree of myopia, but found education level was a stronger factor. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.